Longevity science

A new volume has been published in the growing database of cancer knowledge. This 'Book of cancer knowledge' is predicted to speed up the development of new cancer drugs.

This new data compilation includes details on how many types of cancer cells react to various anti-cancer chemicals. The hope is that this brings us closer to personalized cancer medicine.

Scientists report promising results for an experimental pancreatic cancer drug treatment.

More than 80% of patients with pancreatic cancer die within a year of diagnosis. This sad prognosis has prompted Cancer Research UK to allocate more funds to related treatments. Pancreatic cancer is the fifth most common cause of death by cancer in the UK.

In initial trials, the new drug has been seen to shrink tumors. Next up-- clinical trials, which will involve about 60 patients.

The Indian Patent Office ruled that a local generic drug maker can make and sell a knock-off of drug giant Bayer's exclusive Nexavar,  a cancer drug.

This is only the second time in history that a nation has issued a compulsory license for cancer medication.

Experts believe that this may threaten the big business of global pharmaceutical firms...